Cancer-Fighting super cells tested in solid tumors
NCT ID NCT05194735
First seen Nov 10, 2025 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This study tested a personalized treatment where a patient's own immune cells were genetically modified to recognize and attack unique markers on their cancer. The trial included people with advanced solid tumors like lung, pancreatic, and ovarian cancer who had not responded to standard treatments. The study was stopped early after enrolling only 8 participants, and the main focus was on safety and finding the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.